We investigated whether circulating tumor cell (CTC) count adds prognostic value in ER-positive MBC using immunohistochemical (IHC) or 16α-[<sup>18</sup>F]-fluoro-17β-estradiol (FES)-PET imaging. Here, ESR1 is linked to neoplasm.